BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, April 5, 2026
Home
»
Topics
»
Regulatory
» EMA
EMA
RSS
Tandemact recommended for approval in E.U.
Oct. 23, 2006
European CHMP issues positive opinion on Diacomit submission
Oct. 23, 2006
Adrovance recommended for approval in E.U.
Oct. 23, 2006
Novo Nordisk withdraws E.U. application to expand repaglinide product labels
Oct. 18, 2006
Withdrawal of E.U. marketing authorization for Fortovase
Aug. 14, 2006
Negative opinion handed down for Valdoxan/Thymanax in Europe
Aug. 3, 2006
Positive opinion handed down in Europe for Ganfort
March 28, 2006
Alcon withdraws European submission for Retaane
March 3, 2006
Alcon withdraws application to extend European approval of Opatanol
Feb. 28, 2006
February meeting of European Committee for Orphan Medicinal Products
Feb. 18, 2005
Previous
1
2
…
152
153
154
155
156
157
158
159
160
Next